CDKI-83

CAT: 0804-HY-123034Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-123034Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDKI-83 is a potent CDK9 and CDK1 inhibitor with Ki values of 21 nM and 72 nM for CDK9/T1 and CDK1/B, respectively. CDKI-83 demonstrates effective anti-proliferative activity in human tumour cell lines with a GI50apoptosis in A2780 human ovarian cancer cells. CDKI-83 reduces phosphorylation at Ser-2 of RNA polymerase II (RNAPII) by inhibiting cellular CDK9 activity, and down-regulates Mcl-1 and Bcl-2. CDKI-83 has the potential for anti-cancer research[1].
CAS Number
[1189558-88-0]
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; CDK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdki-83.html
Smiles
N#CC1=CN=C(N=C1C2=C(N=C(S2)NC)C)NC3=CC=C(C(S(=O)(N4CCOCC4)=O)=C3)C
Molecular Formula
C21H23N7O3S2
Molecular Weight
485.58
References & Citations
[1]Xiangrui Liu, et al. In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83. Invest New Drugs. 2012 Jun;30 (3) :889-97.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK1; CDK2; CDK4; CDK7; CDK9

Related Products

CatalogName
HY-169557CDKI-IN-1
HY-155969EGFR-IN-83
HY-10432-01A 83-01
HY-168465α-Glucosidase-IN-83
HY-18287-01MRT-83
HY-110238-01MK6-83
HY-169923HDAC-IN-83
HY-175814NLRP3-IN-83
HY-170775AChE-IN-83
HY-168607ALK5-IN-83

Alternative Products

CatalogName
MBS5813826CDKI-83
MBS5811396CDKi Hydrochloride
MF-0016164-01CDKI-73
MF-0113040-01CDKI-IN-1
A21467-5Asnuciclib (CDKI-73) 5mg
A21467-10Asnuciclib (CDKI-73) 10mg
A21467-100Asnuciclib (CDKI-73) 100mg
A21467-25Asnuciclib (CDKI-73) 25mg
A21467-1Asnuciclib (CDKI-73) 1mg
A21467-2Asnuciclib (CDKI-73) 2mg

Popular Products